Reprint

Prevention and Treatment of Sarcopenia

Edited by
June 2021
288 pages
  • ISBN978-3-0365-1536-6 (Hardback)
  • ISBN978-3-0365-1535-9 (PDF)

This is a Reprint of the Special Issue Prevention and Treatment of Sarcopenia that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary
Sarcopenia represents the decline in skeletal muscle mass and function with age, characterized by the muscle fiber's quality, strength, muscle endurance, and metabolic ability decreasing, as well as the fat and connective tissue growing.Reduction of muscle strength with aging leads to loss of functional capacity, causing disability, mortality, and other adverse health outcomes. Because of the increase of the proportion of elderly in the population, sarcopenia-related morbidity will become an increasing area of health care resource utilization.Diagnostic screening consists of individuation of body composition, assessed by DEXA, anthropometry, bioelectrical impedance, MRI, or CT scan. Management is possible with resistance training exercise and vibration therapy, nutritional supplements, and pharmacological treatment.The book includes articles from different nationalities, treating the experimental and medical applications of sarcopenia. The consequences of sarcopenia in frailty are treated in relation to other associated pathologies or lesions, as femoral neck fractures and hepatocellular carcinoma.

Related Books

September 2022

Prevention and Management of Frailty

Public Health & Healthcare
December 2018

Dietary Protein and Muscle in Aging People

Public Health & Healthcare
February 2024

Age-Related Musculoskeletal Disorders

Biology & Life Sciences
February 2025

Nutrition Interventions for Healthy Ageing

Public Health & Healthcare

The recommendations have been generated using an AI system.